NASDAQ
Innate Pharma S.A. (IPHA) has a fcf yield of -38.15% as of Friday, May 29, 2026. This represents a 221.26% decrease compared to its 12-month average of -11.88%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.